Search results
Q&A: When will patients see personalized cancer vaccines?
Medical Xpress· 1 week agoCatherine Wu has been a pioneer in a promising approach to fight cancer: vaccines that target...
Scientists team up to expand vaccine science's role in the fight against MRSA and other infections
Medical Xpress· 1 day agoIn a Nature Communications study Huang and his collaborators have reported a breakthrough that will...
Spark co-founder, Harvard professor launch Watertown biotech with $54M - Boston Business Journal
The Business Journals· 6 days agoThe company’s science builds on research from its scientific co-founder, Jonathan Kagan, who is a...
Building Better Antibodies and Curbing Autoimmune Diseases
Technology Networks· 1 week agoFour new studies led by Harvard Medical School researchers at Boston Children’s Hospital reveal...
Developing Research into Mpox Infections
Newswise· 1 week agoThe study has continued in the Martinot Lab at Cummings School of Veterinary Medicine at Tufts University by a team of faculty and students researching...
Newswise Expert | Amanda Martinot, Tufts University
Newswise· 1 week agoAmanda Martinot, D.V.M., M.P.H., Ph.D., DACVP, is assistant professor in the Department of Infectious Diseases and Global Health. She joined Cummings S
James Whittle, PhD
The National Law Review· 4 days agoJames is an experienced patent attorney and accomplished research scientist who advises life sciences companies on patent prosecution matters. James works primarily with start-up ...
...from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in...
Morningstar· 3 days agoBiotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills ...
Drugmakers' low U.S. taxes belie their high sales
NPR· 1 week ago"These findings are striking because they show that the companies want to benefit from the high prices and the high sales in the U.S. market, but are...
Paxlovid COVID Treatment Is Most Beneficial for Unvaccinated People with Risk Factors. Others May...
Scientific American· 2 weeks agoThe novel antiviral drug Paxlovid swiftly entered the U.S. pharmaceutical market in late 2021 as an...
